🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔬 I/R is a challenge in AMI treatment. Here we studied timing of LV unloading, mechanisms of cardioprotection, a drug intervention (rosiglitazone) 🫀Unloading+reperfusion ⬆️ myocardial salvage by 47%, linked to PPARG! Could TZDs enhance cardioprotection? biorxiv.org/content/10.110…

Join us for the 13th Annual Utah Cardiac Recovery Symposium (U-CARS) on February 20-21, 2025! 🫀 This event will highlight the latest advancements in myocardial recovery and regeneration. 🔬 Watch the live feed broadcast here: tristalong9.wixsite.com/ucarslivefeed2… #UCARS2025 Stavros George Drakos

Thank you to everyone for your support of #UCARS25!

Congrats Christos P. Kyriakopoulos and team! In this cohort of CS patients transferred from spoke to hub 🏥, we identified 🔑 factors, both inherent and management-related, linked to better outcomes. Insights to help guide escalation of care! UC San Diego Cardiology Fellows UC San Diego Cardiology

Study of CS patients transferred from spoke to hub: shorter LOS, lower spoke care level, lower VIS at hub admission and shorter CS onset-to-MCS linked to ⬆️ native heart survival. #AHAJournals Christos P. Kyriakopoulos Stavros George Drakos University of Utah Health U of U Cardiovascular Medicine UofU Nora Eccles Harrison CVRTI ahajrnls.org/4hQYz2P

Thrilled to congratulate my mentor, Stavros Stavrakis , on being named the inaugural Director of Electrophysiology at OU! As an NIH-funded researcher, Vice Chair of the CV Section, and PD of EP, his leadership and dedication to education will continue to elevate our program.

Excited to share this piece in Sensible Medicine! Reflections on residency training, illness, and advice for incoming interns. sensible-med.com/p/intern-year-…

Thrilled to share our work on the cost-effectiveness of MCS in refractory cardiogenic shock #ISHLT2025. Grateful to my mentors & collaborators! Energized by the science and inspired by the people Stavros George Drakos Christos P. Kyriakopoulos Theo Giannouchos Thomas Hanff, MD MSCE UC San Diego Cardiology Fellows

Proud of Dr Christos P. Kyriakopoulos and our team! Hard work and dedication always pays back in several ways! Keep it up! #ISHLT2025

1/. The VAD WEAN Recovery Network had a strong collaborative presence at #ISHLT2025 : nine (9) projects were presented by our co-investigators from centers around the world 🌎 🌍 Attached list of projects, map with sites & Steering Committee (SC) & Working Groups (WG) chairs

Left Atrial Reverse Remodeling in Patients Supported with Durable Left Ventricular Assist Devices and Clinical Implications Josef Stehlik Thomas Hanff, MD MSCE Joseph Taleb Christos P. Kyriakopoulos Stavros George Drakos University of Utah Health U of U Cardiovascular Medicine University of Utah Department of Internal Medicine UofU Nora Eccles Harrison CVRTI #AHAJournals ahajrnls.org/4koqXKf

Excited to share our recent study on LA reverse remodeling in pts on LVAD support Circ: Heart Failure !! Key findings: - LA structure & function improve early & assoc w/ LV changes - Assoc w/ ⬇️ all-cause mortality & restoration to NSR - Implications for pts w/ earlier stage HF and AFib

🧵 New study out now in JACC: Basic to Translational Science! 🔗 sciencedirect.com/science/articl… 👇 A thread on PCSK9 inhibition, post-MI inflammation, and cardiac remodeling:

PROs provide valuable insight into pts health status, but can they be used to improve risk prediction in HF? 💡In this study, adding PROs to risk models improved ability to predict adverse events. How does your HF program utilize PRO assessments? 🔗 bit.ly/3FjX9j6

Excited to share our latest work with Dr. Schreck on clinical experience with tovorafenib in adults with treatment-refractory high and low-grade gliomas academic.oup.com/nop/article-ab…